Eugene Ivanov Email & Phone Number

Boston, MA, US

City Of London, England, GB

• Design and manage external crowdsourcing campaigns for Fortune 500 companies, government agencies, and non-profit organizations.
• Work with clients helping them identify and define challenges suitable for crowdsourcing and transform this knowledge into compelling problem statements.
• Manage full project life cycle, from problem definition to evaluating submitted solutions.

Needham, Massachusetts, US

• Co-editor of "Corporate Explorer Fieldbook: How to Build New Ventures in Established Companies" (published by Wiley in August 2023), a collection of tools, methodologies, and techniques to build successful.
• Co-Manager of the Corporate Explorer Club, a LinkedIn group for corporate entrepreneurs interested in creating new ventures within large corporations.

• Ushered Mozilla into previously unfamiliar open innovation territory, gradually expanding its business capabilities while reducing R&D costs. Utilized a “soft” power of innovative thinking (“heavy on influence, light.
• Delivered ~$200K in expected savings by designing and launching a machine-learning competition on Topcoder aimed at generating an algorithm for automatic bug triaging for Mozilla’s web-based bug tracker.
• Designed and launched the company’s first-ever series of internal crowdsourcing competitions spanning new product and technology development topics.
• Engaged external crowdsourcing platforms to hold competitions on browser technology solutions to promote credible online content (MindSumo) and open-source voice technology (HeroX).

Arlington, Virginia, US

• CRDF Global is an independent non-profit organization that promotes international scientific and technical collaboration through grants, technical resources, and training in foreign countries.
• Advised government technology commercialization offices and private innovation funds in several foreign countries (Armenia, Azerbaijan, Georgia, Kazakhstan, and Ukraine) on the design and implementation of technology.
• Worked with international agencies and foreign governments to select the best projects to receive technology commercialization grants.
• Trained aspiring young entrepreneurs to translate their technical innovations into commercially attractive value propositions and startup business plans.

New York, New York, US

Ideaphore LLC set out to build the world's first crowdraising platform, CrowdRaising.co, that allows crowds to pledge time instead of money to support causes or projects they care about.

Used social media tools to develop and deliver value proposition statements to support business development and inbound marketing.

Redwood City, CA, US

Mentor for the BUILD Entrepreneurial program for high-school students in under-resourced Boston communities.

City Of London, England, GB

• Managed portfolios of open innovation projects with responsibility for the entire value chain, including customer acquisition and training, scope definition, delivery of services, and handling of IP and payment issues..
• Launched, managed, and expanded innovation programs for 30+ high-profile clients including pharmaceutical, food, and consumer goods companies (AstraZeneca, Eli Lilly, General Mills, Kraft Foods, Pepsi, P&G, Roche.
• Launched and executed 350+ internal and external InnoCentive Challenges bringing $3.6M+ in posting and success fees.
• Co-developed InnoCentive@Work, a proprietary Challenge-Driven Innovation Platform for internal crowdsourcing.
• Designed and managed InnoCentive’s first Grand Challenge (for Prize4Life) with the award amount of $1M.
• Delivered $200K+ in consulting fees from nonprofit organizations by helping them develop open innovation and crowdsourcing programs.

• As Head of Exploratory Research, built and managed a multidisciplinary team of seven scientists charged with the development of novel protein drugs for the treatment of rare (orphan drug status) hereditary diseases.
• Initiated two major projects (Morquio Syndrome type A and GM1 gangliosidosis) and advanced them to the pre-clinical stage.
• Assessed the applicability of a few promising emerging technologies for therapeutic interventions.

Waltham, MA, US